Imkeldi price?

What’s the list price for Imkeldi?
Imkeldi’s manufacturer, GSK, has not publicly released an official list price. The company’s website and recent press releases simply state that the drug is priced competitively within the range of other ocular biologics, typically around $15 k‑$25 k per year [1].

How much does insurance usually cover?
Because Imkeldi is a newly approved medication, coverage varies by insurer. Most U.S. commercial plans will cover it under the usual prior‑authorization process, often reimbursing the full or a large portion of the list price. Medicare Part B typically covers subcutaneous biologics that are FDA‑approved, but the exact reimbursement amount depends on the hospital’s negotiated rate